Liver resection at the time of secondary cytoreduction in ovarian cancer

Background: Hepatic involvement in recurrent ovarian cancer has historically been considered a relative contraindication to cytoreductive surgery. Advances in hepatobiliary surgery and multidisciplinary collaboration have expanded the role of liver resection (Farges et al., 2012, Fong et al., 2005, Hiatt et al., 1994, Curley and Glazer, 2025. This video demonstrates the technical considerations and feasibility of hepatic resection during secondary cytoreductive surgery for ovarian cancer. Case: A 61-year-old woman with early-stage ovarian cancer and a long disease-free interval developed an isolated hepatic recurrence. Imaging revealed a centrally necrotic mass in the right hepatic lobe with contiguous involvement of the right adrenal gland. Biopsy confirmed metastatic high-grade Müllerian carcinoma. Following systemic chemotherapy with radiographic response, the patient was selected for secondary cytoreductive surgery. Surgical technique: The procedure included partial hepatectomy of segments V and VI with en bloc right adrenalectomy and cholecystectomy. Small-volume pelvic disease was removed via low anterior rectal resection, achieving complete gross tumor resection. The video highlights hepatic mobilization, identification of key anatomic landmarks including the hepatoduodenal ligament, Glissonian pedicles, and hepatic venous structures, and parenchymal transection using the clamp-crush technique with vascular control via the Pringle maneuver. Intraoperative ultrasound confirmed vascular anatomy and perfusion of the remnant liver.OutcomeEstimated blood loss was 450 mL with a Pringle time of 25 min. Pathology confirmed metastatic high-grade Müllerian adenocarcinoma with negative hepatic margins. The patient was discharged on postoperative day ten without major postoperative complications. Conclusion: Hepatic resection during secondary cytoreductive surgery for ovarian cancer is safe and feasible in carefully selected patients when performed by experienced multidisciplinary teams with detailed knowledge of hepatic anatomy.

Authors

Institutions

Publication Details

Journal
Gynecologic Oncology Reports
Published
2026-04-01
DOI
https://doi.org/10.1016/j.gore.2026.102022
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Liver resection at the time of secondary cytoreduction in ovarian cancer

Lindsey Finch, Christina Harlev, Kevin Soares, William R. Jarnagin et al.
Gynecologic Oncology Reports
Ovarian cancer diagnosis and treatment
article

Liver resection at the time of secondary cytoreduction in ovarian cancer

Lindsey Finch, Christina Harlev, Kevin Soares, William R. Jarnagin, Dennis S. Chi
article en

Abstract

Background: Hepatic involvement in recurrent ovarian cancer has historically been considered a relative contraindication to cytoreductive surgery. Advances in hepatobiliary surgery and multidisciplinary collaboration have expanded the role of liver resection (Farges et al., 2012, Fong et al., 2005, Hiatt et al., 1994, Curley and Glazer, 2025. This video demonstrates the technical considerations and feasibility of hepatic resection during secondary cytoreductive surgery for ovarian cancer. Case: A 61-year-old woman with early-stage ovarian cancer and a long disease-free interval developed an isolated hepatic recurrence. Imaging revealed a centrally necrotic mass in the right hepatic lobe with contiguous involvement of the right adrenal gland. Biopsy confirmed metastatic high-grade Müllerian carcinoma. Following systemic chemotherapy with radiographic response, the patient was selected for secondary cytoreductive surgery. Surgical technique: The procedure included partial hepatectomy of segments V and VI with en bloc right adrenalectomy and cholecystectomy. Small-volume pelvic disease was removed via low anterior rectal resection, achieving complete gross tumor resection. The video highlights hepatic mobilization, identification of key anatomic landmarks including the hepatoduodenal ligament, Glissonian pedicles, and hepatic venous structures, and parenchymal transection using the clamp-crush technique with vascular control via the Pringle maneuver. Intraoperative ultrasound confirmed vascular anatomy and perfusion of the remnant liver.OutcomeEstimated blood loss was 450 mL with a Pringle time of 25 min. Pathology confirmed metastatic high-grade Müllerian adenocarcinoma with negative hepatic margins. The patient was discharged on postoperative day ten without major postoperative complications. Conclusion: Hepatic resection during secondary cytoreductive surgery for ovarian cancer is safe and feasible in carefully selected patients when performed by experienced multidisciplinary teams with detailed knowledge of hepatic anatomy.

Gynecologic Oncology ReportsVol. 64
Memorial Sloan Kettering Cancer Center (US), Cornell University (US)
National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 23%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.